BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22350850)

  • 1. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
    Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
    Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP promotes neuron survival in early experimental diabetic retinopathy.
    Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
    Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
    Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
    Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
    Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS
    Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
    Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
    Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
    D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
    J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
    Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
    Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
    Qin Y; Xu G; Fan J; Witt RE; Da C
    Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.
    Wurm A; Iandiev I; Hollborn M; Wiedemann P; Reichenbach A; Zimmermann H; Bringmann A; Pannicke T
    Exp Eye Res; 2008 Oct; 87(4):385-93. PubMed ID: 18687327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.
    Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J
    Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylyl cyclase-activating polypeptide receptor re-sensitization induces plastic changes in the dopaminergic phenotype in the mature avian retina.
    Fleming RL; Silveira MS; Santos LE; Henze IP; Gardino PF; de Mello MC; de Mello FG
    J Neurochem; 2013 Mar; 124(5):621-31. PubMed ID: 23227973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.